Paul Lewicki, PhD

Dr. Paul Lewicki PhD joined the Board in November 2020. He is a cognitive scientist, entrepreneur and investor. Dr. Lewicki co-founded Holo Surgical Inc. and most recently served as its President from 2016 until its acquisition by Surgalign in 2020.  Dr. Lewicki previously served as Chief Executive Officer of StatSoft, a company he founded that pioneered commercial applications of big data learning and data mining and became a developer of data mining solutions for all industries, until StatSoft was acquired by Dell in 2014.  Dr. Lewicki is a former professor of cognitive psychology at the University of Tulsa (1984—2009). Dr. Lewicki currently serves on the board of directors of Dystrogen Therapeutics Inc., and Kardiolytics Inc.  Dr. Lewicki received his PhD at the University of Warsaw (Poland).  Dr. Lewicki is a thought leader in predictive analytics and has a deep passion for the use of artificial intelligence to promote general access to advanced medical procedures and the general welfare by accelerating technology progress in medicine.  Dr. Lewicki’s experience with artificial intelligence and machine learning in the medical technology space, particularly with Holo Surgical and Inteneural Networks, provides our Board with valuable industry expertise and make him well qualified to serve as a member of our Board.